Compare GRFS & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | SIRI |
|---|---|---|
| Founded | 1940 | 2013 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.3B |
| IPO Year | N/A | 1996 |
| Metric | GRFS | SIRI |
|---|---|---|
| Price | $8.71 | $22.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 8 |
| Target Price | $10.15 | ★ $25.00 |
| AVG Volume (30 Days) | 608.0K | ★ 5.5M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | 1.65% | ★ 4.86% |
| EPS Growth | N/A | ★ 136.32 |
| EPS | N/A | ★ 2.23 |
| Revenue | N/A | ★ $5,425,129,000.00 |
| Revenue This Year | $5.33 | $1.81 |
| Revenue Next Year | $6.50 | $0.65 |
| P/E Ratio | $18.67 | ★ $9.95 |
| Revenue Growth | N/A | ★ 8.13 |
| 52 Week Low | $6.19 | $18.69 |
| 52 Week High | $11.14 | $25.36 |
| Indicator | GRFS | SIRI |
|---|---|---|
| Relative Strength Index (RSI) | 39.04 | 67.49 |
| Support Level | $8.66 | $22.76 |
| Resistance Level | $9.11 | $23.45 |
| Average True Range (ATR) | 0.27 | 0.53 |
| MACD | -0.08 | 0.15 |
| Stochastic Oscillator | 27.18 | 99.52 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
SiriusXM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates, and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.